Literature DB >> 27570707

Pesg PNH diagnosis, follow-up and treatment guidelines.

Fahri Sahin1, Olga Meltem Akay2, Mesut Ayer3, Mehmet Sinan Dal4, Sehmus Ertop5, Osman Ilhan6, Volkan Karakus7, Mehmet Ali Ozcan8, Vildan Ozkocaman9, Hayri Ozsan8, Ozan Salim10, Mahmut Tobu1, Anil Tombak11, Tulin Firatli Tuglular12, Mehmet Yilmaz13, Ali Unal14, Mustafa Nuri Yenerel12, Guray Saydam15.   

Abstract

PNH Education and Study Group (PESG) have been established in December 2013 as a non-profit, independent, medical organization www.pesg.org. Paroxysmal Nocturnal Hemoglobinuria (PNH) is a multi-systemic disease that should be treated with a multidisciplinary approach. Patients may apply to the clinics other than the hematology due to variability and diversity of clinical findings which lower the rate of diagnosis due to low awareness about PNH. PNH might be overlooked and diagnosis might be delayed. Regarding these, PESG was established with the collaboration of Immunology, Cardiology, Thorax Diseases (Pulmonology), Neurology, Gastroenterology, General Surgery and Urology specialists in addition to hematologists dealing with PNH. The PESG study group aims to increase the awareness about PNH, including training activities about PNH, strengthening the relations between clinics and planning of clinical studies as a goal. It is the first professional organization focusing on PNH, in Turkey.In this guideline, we want to facilitate the diagnosis attributes of physicians from all specializations that deal with PNH and its systemic complications. One can perceive this as a tailor made guideline of international guidelines but not a compilation.

Entities:  

Keywords:  PNH; diagnosis; guideline; treatment

Year:  2016        PMID: 27570707      PMCID: PMC4981648     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  38 in total

1.  Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry.

Authors:  Michael J Borowitz; Fiona E Craig; Joseph A Digiuseppe; Andrea J Illingworth; Wendell Rosse; D Robert Sutherland; Carl T Wittwer; Stephen J Richards
Journal:  Cytometry B Clin Cytom       Date:  2010-07       Impact factor: 3.058

Review 2.  Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuria.

Authors:  Charles J Parker
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

3.  Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology.

Authors:  G Socié; J Y Mary; A de Gramont; B Rio; M Leporrier; C Rose; P Heudier; H Rochant; J Y Cahn; E Gluckman
Journal:  Lancet       Date:  1996-08-31       Impact factor: 79.321

4.  Variations in the red cells in paroxysmal nocturnal haemoglobinuria.

Authors:  W F Rosse
Journal:  Br J Haematol       Date:  1973-03       Impact factor: 6.998

Review 5.  Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Stephen J Richards; Peter Hillmen
Journal:  Br J Haematol       Date:  2007-05       Impact factor: 6.998

6.  Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin.

Authors:  R A Brodsky; G L Mukhina; K L Nelson; T S Lawrence; R J Jones; J T Buckley
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

7.  Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories.

Authors:  Régis Peffault de Latour; Jean Yves Mary; Célia Salanoubat; Louis Terriou; Gabriel Etienne; Mohamad Mohty; Sophie Roth; Sophie de Guibert; Sebastien Maury; Jean Yves Cahn; Gerard Socié
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

8.  Natural history of paroxysmal nocturnal hemoglobinuria.

Authors:  P Hillmen; S M Lewis; M Bessler; L Luzzatto; J V Dacie
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245

9.  Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky; Neal S Young; Elisabetta Antonioli; Antonio M Risitano; Hubert Schrezenmeier; Jörg Schubert; Anna Gaya; Luke Coyle; Carlos de Castro; Chieh-Lin Fu; Jaroslaw P Maciejewski; Monica Bessler; Henk-André Kroon; Russell P Rother; Peter Hillmen
Journal:  Blood       Date:  2007-11-30       Impact factor: 22.113

10.  Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.

Authors:  Peter Hillmen; Petra Muus; Alexander Röth; Modupe O Elebute; Antonio M Risitano; Hubert Schrezenmeier; Jeffrey Szer; Paul Browne; Jaroslaw P Maciejewski; Jörg Schubert; Alvaro Urbano-Ispizua; Carlos de Castro; Gérard Socié; Robert A Brodsky
Journal:  Br J Haematol       Date:  2013-04-25       Impact factor: 6.998

View more
  3 in total

1.  Nephrotic-range proteinuria and brown urine in an 8-year-old girl: Answers.

Authors:  Emilie Saucier; Julien Hogan; Michel Peuchmaur; Georges Deschênes; Andre Baruchel; Vasiliki Karava
Journal:  Pediatr Nephrol       Date:  2017-09-18       Impact factor: 3.714

2.  Upper gastrointestinal ischemia as a rare complication of paroxysmal nocturnal hemoglobinuria.

Authors:  Masayuki Ueno; Yuichi Shimodate; Kazuya Okada; Ryosuke Takaya; Hiroshi Yamamoto; Motowo Mizuno
Journal:  Clin Case Rep       Date:  2020-11-22

3.  Paroxysmal Nocturnal Hemoglobinuria in the Differential Diagnosis of Thrombocytopenia.

Authors:  Fusun Gediz; Bahriye Kadriye Payzin; Ozlem Zekiye Cakmak; Yusuf Uzum; Damla Ernur; Fahri Sahin
Journal:  Hematol Rep       Date:  2017-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.